Ifp Advisors, Inc Aerie Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$11.32 - $16.63 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$15.16 - $18.97 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$13.12 - $20.9 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$9.12 - $14.49 $410 - $652	-45 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$10.46 - $14.46 $470 - $650	45 New	45 $1,000
Q2 2020 Aug 05, 2020	BUY	$12.0 - $16.13 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$11.84 - $25.52 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$17.72 - $25.1 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$18.41 - $28.0 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $18,160 - $24,625	-500 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$56.15 - $73.9 $5,615 - $7,390	-100 Reduced 16.67%	500 $0
Q4 2017 Jan 24, 2018	BUY	$50.85 - $65.1 $5,085 - $6,509	100 Added 20.0%	600 $0
Q3 2017 Oct 30, 2017	BUY	$48.6 - $60.1 $4,860 - $6,010	100 Added 25.0%	500 $24,000
Q2 2016 Jun 03, 2019	BUY	N/A	400	400 $7,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.